RSV Infection Linked to Increased Heart & Lung Event Risk in Adults

Recent research indicates a potential link between hospitalization for Respiratory Syncytial Virus (RSV) in adults and an increased risk of cardiovascular and respiratory events for up to six months following discharge. A study analyzing data from nearly 12,000 patients in the United States revealed a significantly elevated risk of conditions like heart attack and stroke in the weeks and months after an RSV hospitalization.

Understanding the Findings

Researchers from Pfizer analysed data from 11,887 patients within the Optum Market Clarity database, covering hospitalizations for RSV between January 2017 and March 2024. The study focused on comparing the incidence of cardiorespiratory events – including myocardial infarction, stroke, exacerbation of chronic obstructive pulmonary disease (COPD), congestive heart failure, and arrhythmias – during a risk period (six months post-hospitalization) versus control periods.

A Previously Underestimated Threat

The study authors noted that RSV has historically been underdiagnosed as a cause of severe respiratory illness in adults. This is attributed to factors like non-specific symptoms, limited testing, restrictive case definitions, and lower viral loads compared to children. This research suggests a more significant impact from RSV than previously understood.

Did You Know? The most frequently observed cardiorespiratory event following RSV hospitalization was arrhythmia, affecting 5,844 patients in the study.

The highest risk for all cardiorespiratory events was observed within the first 14 days of hospitalization, particularly during the first week. For example, the rate of heart attack was 8.7 times higher during the first seven days after an RSV hospitalization. The risk remained elevated for several weeks, with a relative risk of 1.8 for heart attack and stroke up to 63 days post-hospitalization, and 1.5 for congestive heart failure exacerbation up to 84 days.

Context with Other Respiratory Illnesses

Researchers acknowledge that other respiratory illnesses, such as influenza and SARS-CoV-2, have also been linked to cardiovascular events. However, the connection between RSV and these complications hasn’t been as clearly established until now. The study highlights a potential role for RSV in triggering cardiorespiratory issues, especially in older adults.

Expert Insight: This research underscores the importance of recognizing RSV as a potentially serious health risk for adults, not just infants and young children. The prolonged risk of cardiovascular events following hospitalization suggests a need for increased vigilance and potentially altered post-discharge care protocols.

The study’s findings support the current recommendations from the centres for Disease Control and Prevention (CDC) for RSV vaccination in adults aged 60 and older, particularly those with underlying cardiovascular or respiratory conditions. Further research is needed to fully understand how RSV contributes to these complications and its potential links to conditions like asthma and COPD.

Frequently Asked Questions

What cardiorespiratory events were studied?

The study examined myocardial infarction (heart attack), stroke, exacerbation of chronic obstructive pulmonary disease (COPD), exacerbation of congestive heart failure (ICC), and arrhythmias (irregular heartbeats).

What percentage of study participants were female?

Approximately 61.4% of the 11,887 participants included in the study were female.

How long after hospitalization was the risk of events elevated?

The risk of cardiorespiratory events remained significantly elevated for up to six months after hospitalization for RSV, with some events, like heart attack and stroke, showing elevated risk up to 63 days, and congestive heart failure exacerbation up to 84 days.

As awareness of RSV’s potential impact on adult health grows, what steps do you think healthcare providers and individuals should take to mitigate these risks?